These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19545205)

  • 1. Future of polio vaccines.
    Ehrenfeld E; Modlin J; Chumakov K
    Expert Rev Vaccines; 2009 Jul; 8(7):899-905. PubMed ID: 19545205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virology. 'Biased' viruses suggest new vaccine strategy for polio and other diseases.
    Enserink M
    Science; 2008 Jun; 320(5884):1709. PubMed ID: 18583587
    [No Abstract]   [Full Text] [Related]  

  • 3. Polio vaccination: past, present and future.
    Bandyopadhyay AS; Garon J; Seib K; Orenstein WA
    Future Microbiol; 2015; 10(5):791-808. PubMed ID: 25824845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.
    Gajdos V; Soubeyrand B; Vidor E; Richard P; Boyer J; Sadorge C; Fiquet A
    Hum Vaccin; 2011 May; 7(5):549-56. PubMed ID: 21441781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.
    Duintjer Tebbens RJ; Thompson KM
    Future Microbiol; 2016 Dec; 11():1549-1561. PubMed ID: 27831742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.
    Knowlson S; Burlison J; Giles E; Fox H; Macadam AJ; Minor PD
    PLoS Pathog; 2015 Dec; 11(12):e1005316. PubMed ID: 26720150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective inactivated or live poliovirus vaccine: effectiveness in the 21st Century.
    Arya SC; Agarwal N
    Expert Rev Vaccines; 2009 Feb; 8(2):127-30. PubMed ID: 19196189
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany.
    Eggers M; Terletskaia-Ladwig E; Rabenau HF; Doerr HW; Diedrich S; Enders G; Enders M
    BMC Infect Dis; 2010 Dec; 10():347. PubMed ID: 21143885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging/disappearing viruses future issues concerning polio eradication.
    Minor P
    Virus Res; 2002 Jan; 82(1-2):33-7. PubMed ID: 11885947
    [No Abstract]   [Full Text] [Related]  

  • 14. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new polio eradication end game: rationale and supporting evidence.
    Sutter RW; Platt L; Mach O; Jafari H; Aylward RB
    J Infect Dis; 2014 Nov; 210 Suppl 1():S434-8. PubMed ID: 25316865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against polio should not be stopped.
    Chumakov K; Ehrenfeld E; Wimmer E; Agol VI
    Nat Rev Microbiol; 2007 Dec; 5(12):952-8. PubMed ID: 17965726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
    Minor P
    Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from OPV to IPV: are we behind the schedule in Latin America?
    Salas-Peraza D; Avila-Agüero ML; Morice-Trejos A
    Expert Rev Vaccines; 2010 May; 9(5):475-83. PubMed ID: 20450322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.